Treatment for Migraine and Mood

The researchers propose a three-arm pilot study of Mindfulness-Based Cognitive Therapy (MBCT) delivered via telephone (MBCT-T), video (MBCT-V) or Enhanced Usual Care (EUC).

Inclusion Criteria: * Currently meets ICHD-3 criteria for migraine using the American Migraine Prevalence and Prevention Diagnostic Module * Self-reported 4-20 headache days per month * Score between 5-19 on the PHQ-8 * Age ≥ 18 * Ability to read and speak English * Capacity to consent * ≥1 year of migraine Exclusion Criteria: * Meeting ICHD-3 criteria for persistent headache attributed to traumatic injury to the head (post- traumatic headache) on the American Migraine Prevalence and Prevention Diagnostic Module * Changes in anti-depressant medication within 6 weeks of intake * Starting or changing a migraine preventive treatment (i.e., oral medication, injection, preventive medicine, neuromodulatory device) within 12 weeks of intake * Changes in acute migraine treatment started within 4 weeks of enrollment * Comorbid psychiatric illness or clinical features that would interfere with participant's ability to participate in or receive benefit from the MBCT-T intervention, including but not limited to: active suicidal ideation; current or recent history (in the last six months) of psychosis or mania; borderline, histrionic or narcissistic personality disorder; cognitive impairment; sensory disabilities;, discomfort participating in a group-based intervention, drug use * Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy * Current daily meditation practice * Unwilling to maintain stable current acute or preventive medication dosages for study duration * Any condition that would prevent being a suitable candidate for the group intervention * Medication overuse headache with migraine treatment